AAAAAA

   
Results: 1-13 |
Results: 13
Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins - A mechanism for atherogenic lipid accumulation
Authors: Guyton, JR
Citation: Jr. Guyton, Phospholipid hydrolytic enzymes in a 'cesspool' of arterial intimal lipoproteins - A mechanism for atherogenic lipid accumulation, ART THROM V, 21(6), 2001, pp. 884-886
Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol
Authors: Guyton, JR Blazing, MA Hagar, J Kashyap, ML Knopp, RH McKenney, JM Nash, DT Nash, SD
Citation: Jr. Guyton et al., Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol, ARCH IN MED, 160(8), 2000, pp. 1177-1184
Dual hepatic metabolism of cerivastatin-clarifications
Authors: Guyton, JR Dujovne, CA Illingworth, DR
Citation: Jr. Guyton et al., Dual hepatic metabolism of cerivastatin-clarifications, AM J CARD, 84(4), 1999, pp. 497-497
Treatment of type III hyperlipoproteinemia
Authors: Guyton, JR
Citation: Jr. Guyton, Treatment of type III hyperlipoproteinemia, AM HEART J, 138(1), 1999, pp. 17-18
Overview of pathology: The vulnerable plaque and complications of atherosclerosis
Authors: Fuster, V Falk, E Bassiouny, HS Fallon, JT Guyton, JR",Taubman,"Libby, P
Citation: V. Fuster et al., Overview of pathology: The vulnerable plaque and complications of atherosclerosis, AM HEART MG, 1999, pp. 59-65
Lipids in atherosclerotic lesion progression
Authors: Guyton, JR
Citation: Jr. Guyton, Lipids in atherosclerotic lesion progression, AM HEART MG, 1999, pp. 277-286
A symposium: New advances in dyslipidemia - Introduction
Authors: Kwiterovich, PO Guyton, JR
Citation: Po. Kwiterovich et Jr. Guyton, A symposium: New advances in dyslipidemia - Introduction, AM J CARD, 82(12A), 1998, pp. 1U-2U
Effect of niacin on atherosclerotic cardiovascular disease
Authors: Guyton, JR
Citation: Jr. Guyton, Effect of niacin on atherosclerotic cardiovascular disease, AM J CARD, 82(12A), 1998, pp. 18U-23U
A new extended-release niacin (Niaspan): Efficacy, tolerability, and safety in hypercholesterolemic patients
Authors: Morgan, JM Capuzzi, DM Guyton, JR
Citation: Jm. Morgan et al., A new extended-release niacin (Niaspan): Efficacy, tolerability, and safety in hypercholesterolemic patients, AM J CARD, 82(12A), 1998, pp. 29U-34U
Advances in dyslipidemia: Discussion session I
Authors: Kwiterovich, PO Knopp, RH Morgan, JM Guyton, JR Goldberg, AC
Citation: Po. Kwiterovich et al., Advances in dyslipidemia: Discussion session I, AM J CARD, 82(12A), 1998, pp. 39U-41U
Efficacy and safety of an extended-release niacin (Niaspan): A long-term study
Authors: Capuzzi, DM Guyton, JR Morgan, JM Goldberg, AC Kreisberg, RA Brusco, OA Brody, J
Citation: Dm. Capuzzi et al., Efficacy and safety of an extended-release niacin (Niaspan): A long-term study, AM J CARD, 82(12A), 1998, pp. 74U-81U
Treatment of hyperlipidemia with combined niacin-statin regimens
Authors: Guyton, JR Capuzzi, DM
Citation: Jr. Guyton et Dm. Capuzzi, Treatment of hyperlipidemia with combined niacin-statin regimens, AM J CARD, 82(12A), 1998, pp. 82U-84U
Advances in dyslipidemia: Discussion session II
Authors: Guyton, JR Capuzzi, DM Kreisberg, RA Sprecher, DL Marcovina, SM Kashyap, ML
Citation: Jr. Guyton et al., Advances in dyslipidemia: Discussion session II, AM J CARD, 82(12A), 1998, pp. 85U-86U
Risultati: 1-13 |